← Back to Search

Pathways for Lung Cancer

N/A
Waitlist Available
Led By Laurie McLouth, PhD
Research Sponsored by Laurie McLouth
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
new or recurrent stage IIIB, stage IIIC or stage IV non-small cell lung cancer (NSCLC) or extensive stage SCLC
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights

Study Summary

This trial will test whether the Pathways intervention can help patients with advanced stage and metastatic lung cancer.

Eligible Conditions
  • Lung Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability: Ratings
Feasibility of Enrollment: Percentage of Eligible and Approached Patients Who Agree to Participate
Secondary outcome measures
Distress - PROMIS Depression Short Form 6a
Hope - State Hope Scale (Snyder)
Lung Cancer Stigma - Lung Cancer Stigma Inventory (Hamann)
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: PathwaysExperimental Treatment1 Intervention
Pathways is designed to help patients identify and pursue values-based goals and address potential goal obstacles, including lung cancer stigma.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pathways
2020
N/A
~1140

Find a Location

Who is running the clinical trial?

Laurie McLouthLead Sponsor
3 Previous Clinical Trials
354 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,613 Previous Clinical Trials
40,918,262 Total Patients Enrolled
Laurie McLouth, PhDPrincipal Investigator - University of Kentucky
University of Kentucky
2 Previous Clinical Trials
314 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Mar 2025